恭賀! 第11屆中華民國製藥發展協會理事長選舉出爐 ! Congratulation ! New President of Taiwan Pharmaceutical Manufacture and Development Association
We are excited to announce that Dr. Lee, FangChen, Director of YungShin Pharmaceutical Industrial Co, Ltd, is our new president of Taiwan Pharmaceutical Manufacture and Development Association, said Dr. Wu Chang Chuang, Executive director of Taiwan Pharmaceutical Manufacture and development association-cum-President of Sun Ten Pharmaceutical Co, Ltd here to congratulate Dr. Lee’s election victory with Sun Ten Group.
Dr. Lee devote his life to pharmaceutical industry. Since 2007, Sun Ten and Yung Shin started a joint venture in Malaysia via Singapore to cultivate local nature herbal market, and today, thirteen years later, our reward has been truly encouraging!
In 2020, Although the global has been facing Covid-19 influencing our lives, politics, and economics seriously, Taiwan could still react soon and minimize the influence. Taiwan are now helping countries of the world to confront this pandemic, and this also the time Taiwan Pharmaceutical industry transforming ourselves to a new era, said Dr. Wu Chang Chuang. “We are always there helping any foreign affairs who need us, and we could expect that Dr. Lee, FangChen, our new president of Taiwan Pharmaceutical Manufacture and Development Association will bring us further to be in line with the world. Taiwan can help !
2020年8月6日中華民國製藥發展協會理事長改選結果揭曉，恭賀永信藥品集團李芳全董事當選第11屆中華民國製藥發展協會理事長。順天堂藥廠總經理暨製藥發展協會常務理事莊武璋率集團同仁在此祝賀榮任之喜。
李芳全董事致力於藥品事業發展，順天堂與永信東南亞控股有限公司(YSPSAH)自2007年起在馬來西亞及新加坡合資成立順天堂製藥廠(馬)有限公司及順天堂(新)有限公司在地深耕經營，旨在拓展東南亞的天然草藥業務，當地市場經營成果豐碩。
2020年全球因COVID-19疫情關係，影響政治及經濟發展甚鉅，台灣製藥產業正處於轉變的分歧點上，雖逢此嚴峻時刻，製藥產業夥伴在任何需要台灣協助的國際事務上從未缺席。期許中華民國製藥發展協會在李芳全理事長帶領之下，台灣製藥產業能與全球更加緊密接軌並提供協助。Taiwan can help!
#TaiwanCanHelp #sunten #neweraofTaiwanPharmaceuticalManufactureandDevelopmentAssociation #中華民國製藥發展協會
Share this Post: